Literature DB >> 2112562

Toxin A of Clostridium difficile is a potent cytotoxin.

K D Tucker1, P E Carrig, T D Wilkins.   

Abstract

Clostridium difficile is the cause of antibiotic-associated colitis in humans. The organism produces toxin A, which is generally known as the enterotoxin, and toxin B, which is known as the cytotoxin. Toxin A has been reported to have slight cytotoxic activity; in this study we show that cell lines (F9, OTF9-63, and P19) which express a carbohydrate to which toxin A binds are more sensitive to the toxin. These cell lines can be used as research tools for determining concentrations of biologically active toxin A and should also prove useful for studies of the mechanism of action of the toxin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112562      PMCID: PMC267826          DOI: 10.1128/jcm.28.5.869-871.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Toxin A from Clostridium difficile binds to rabbit erythrocyte glycolipids with terminal Gal alpha 1-3Gal beta 1-4GlcNAc sequences.

Authors:  G F Clark; H C Krivan; T D Wilkins; D F Smith
Journal:  Arch Biochem Biophys       Date:  1987-08-15       Impact factor: 4.013

3.  Purification of Clostridium difficile toxin A by affinity chromatography on immobilized thyroglobulin.

Authors:  H C Krivan; T D Wilkins
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

4.  Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro.

Authors:  A A Lima; D M Lyerly; T D Wilkins; D J Innes; R L Guerrant
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

5.  Purification and characterization of toxins A and B of Clostridium difficile.

Authors:  N M Sullivan; S Pellett; T D Wilkins
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

6.  Differential effects of Clostridium difficile toxins on tissue-cultured cells.

Authors:  S T Donta; N Sullivan; T D Wilkins
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

7.  Production of Clostridium difficile antitoxin.

Authors:  M Ehrich; R L Van Tassell; J M Libby; T D Wilkins
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

8.  Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc.

Authors:  H C Krivan; G F Clark; D F Smith; T D Wilkins
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

9.  Comparison of two toxins produced by Clostridium difficile.

Authors:  N S Taylor; G M Thorne; J G Bartlett
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

10.  Cytotoxicity of plant lectins for mouse embryonal carcinoma cells.

Authors:  P Dráber; P Stanley
Journal:  Somat Cell Mol Genet       Date:  1984-09
View more
  19 in total

Review 1.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Comparative sequence analysis of the Clostridium difficile toxins A and B.

Authors:  C von Eichel-Streiber; R Laufenberg-Feldmann; S Sartingen; J Schulze; M Sauerborn
Journal:  Mol Gen Genet       Date:  1992-05

3.  Antigenic cross-reactivity and functional inhibition by antibodies to Clostridium difficile toxin A, Streptococcus mutans glucan-binding protein, and a synthetic peptide.

Authors:  B W Wren; R R Russell; S Tabaqchali
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

4.  Nucleotide sequence of Clostridium difficile toxin B gene.

Authors:  L A Barroso; S Z Wang; C J Phelps; J L Johnson; T D Wilkins
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

5.  Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease.

Authors:  S P Sambol; M M Merrigan; D Lyerly; D N Gerding; S Johnson
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 6.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

7.  Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells.

Authors:  E Chaves-Olarte; M Weidmann; C Eichel-Streiber; M Thelestam
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

8.  Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions.

Authors:  A Fasano; B Baudry; D W Pumplin; S S Wasserman; B D Tall; J M Ketley; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

9.  Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y.

Authors:  K D Tucker; T D Wilkins
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

10.  Purification and characterization of alpha-toxin produced by Clostridium novyi type A.

Authors:  D W Ball; R L Van Tassell; M D Roberts; P E Hahn; D M Lyerly; T D Wilkins
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.